Systemic or Endoventricular Thrombolysis to Treat HeartWare Left Ventricle Assist Device Thrombosis: A Clinical Dilemma

Publisher： John Wiley & Sons Inc

E-ISSN： 1525-1594|39|6|526-529

ISSN： 0160-564x

Source： ARTIFICIAL ORGANS, Vol.39, Iss.6, 2015-06, pp. : 526-529

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Third Generation Ventricular Assist Device: Mid‐Term Outcomes of the HeartWare HVAD in Pediatric Patients

By  

ARTIFICIAL ORGANS, Vol. 42, Iss. 2, 2018-02 ,pp. : 141-147

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letters to the Editor

By  

ARTIFICIAL ORGANS, Vol. 39, Iss. 3, 2015-03 ,pp. : 288-289

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidence and Risk Factor Analysis for Gastrointestinal Bleeding and Pump Thrombosis in Left Ventricular Assist Device Recipients

By  

ARTIFICIAL ORGANS, Vol. 39, Iss. 11, 2015-11 ,pp. : 939-944

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interventional Occlusion of Left Ventricular Assist Device Outflow Graft After Pump Thrombosis and Partial Myocardial Recovery

By  

ARTIFICIAL ORGANS, Vol. 39, Iss. 8, 2015-08 ,pp. : 729-730

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of an Intercostal Left Ventricular Assist Device Prolapse by Upgrading From HeartMate II to HeartMate 3

By  

ARTIFICIAL ORGANS, Vol. 42, Iss. 2, 2018-02 ,pp. : 242-244

John Wiley & Sons Inc

Access to resources Recommend Favorite